Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Bi-Allelic Hpdl Variants Cause a Neurodegenerative Disease Ranging From Neonatal Encephalopathy to Adolescent-Onset Spastic Paraplegia Publisher Pubmed



Husain RA1 ; Grimmel M2 ; Wagner M3, 4, 5 ; Hennings JC6 ; Marx C7 ; Feichtinger RG8 ; Saadi A9 ; Rostasy K10 ; Radelfahr F11, 12 ; Bevot A13 ; Doblerneumann M13 ; Hartmann H14 ; Colleaux L15 ; Cordts I16 Show All Authors
Authors
  1. Husain RA1
  2. Grimmel M2
  3. Wagner M3, 4, 5
  4. Hennings JC6
  5. Marx C7
  6. Feichtinger RG8
  7. Saadi A9
  8. Rostasy K10
  9. Radelfahr F11, 12
  10. Bevot A13
  11. Doblerneumann M13
  12. Hartmann H14
  13. Colleaux L15
  14. Cordts I16
  15. Kobeleva X17
  16. Darvish H18
  17. Bakhtiari S19
  18. Kruer MC19
  19. Besse A20
  20. Ng ACH21
  21. Chiang D21
  22. Bolduc F21
  23. Tafakhori A22
  24. Mane S23
  25. Ghasemi Firouzabadi S24
  26. Huebner AK6
  27. Buchert R2
  28. Beckwoedl S2
  29. Muller AJ2
  30. Laugwitz L2, 13
  31. Nagele T25
  32. Wang ZQ7, 26
  33. Strom TM3, 4
  34. Sturm M2
  35. Meitinger T3, 4, 27
  36. Klockgether T17, 28
  37. Riess O2, 29
  38. Klopstock T11, 12, 27
  39. Brandl U1
  40. Hubner CA6
  41. Deschauer M16
  42. Mayr JA8
  43. Bonnen PE20
  44. Kragelohmann I13
  45. Wortmann SB3, 4, 8, 30
  46. Haack TB2, 29

Source: American Journal of Human Genetics Published:2020


Abstract

We report bi-allelic pathogenic HPDL variants as a cause of a progressive, pediatric-onset spastic movement disorder with variable clinical presentation. The single-exon gene HPDL encodes a protein of unknown function with sequence similarity to 4-hydroxyphenylpyruvate dioxygenase. Exome sequencing studies in 13 families revealed bi-allelic HPDL variants in each of the 17 individuals affected with this clinically heterogeneous autosomal-recessive neurological disorder. HPDL levels were significantly reduced in fibroblast cell lines derived from more severely affected individuals, indicating the identified HPDL variants resulted in the loss of HPDL protein. Clinical presentation ranged from severe, neonatal-onset neurodevelopmental delay with neuroimaging findings resembling mitochondrial encephalopathy to milder manifestation of adolescent-onset, isolated hereditary spastic paraplegia. All affected individuals developed spasticity predominantly of the lower limbs over the course of the disease. We demonstrated through bioinformatic and cellular studies that HPDL has a mitochondrial localization signal and consequently localizes to mitochondria suggesting a putative role in mitochondrial metabolism. Taken together, these genetic, bioinformatic, and functional studies demonstrate HPDL is a mitochondrial protein, the loss of which causes a clinically variable form of pediatric-onset spastic movement disorder. © 2020 American Society of Human Genetics
Other Related Docs
7. Phenotypic Continuum of Nfu1-Related Disorders, Annals of Clinical and Translational Neurology (2022)